Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab
Abstract Aim The aim of this study was to add robustness and provide further evidence on the bioequivalence, safety and immunogenicity between MB02 and reference bevacizumab. No similar study has been performed before with a biosimilar monoclonal antibody. Methods Population analysis by pooling data...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2023-12-01
|
| Edice: | Pharmacology Research & Perspectives |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/prp2.1139 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|